New research suggests that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who halt conventional lifestyle plans.
Published data in a leading health publication demonstrates that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"People purchasing such medications need to be informed of the risk of rapid rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain means a return to starting weight in about a year and a half.
Comparing Approaches
The research, which looked at 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.
The team note that people who lose weight through diet and exercise generally see a less rapid creep back—around 0.1 kg a month—once they finish.
Explaining the Quick Rebound
Nutrition scientists suggest the mechanism of the injections accounts for the heightened rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of the hormone levels several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication means appetite is unsuppressed, making binge eating much more probable."
A Chronic Condition?
The NHS suggest the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.
A number of clinicians contend that, due to the likelihood of weight regain, the therapy might need to be ongoing.
This view is supported by pharmaceutical companies, who state that the results "emphasize the persistent nature of excess weight," akin to managing diseases like hypertension.
User Testimonies
Individuals who have stopped the jabs report a intense resurgence of cravings.
"It was like a trigger that goes on and you become starving," described an individual.
This challenge is exacerbated if users have not adopted permanent lifestyle or habit changes during therapy.
Growing Interest
Recent estimates indicate that a significant number of adults in the UK have used these injections in the past year, with demand remaining high.
- Use is higher among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
Finally, clinicians emphasize that while these medications are effective agents for weight loss, they are not a magic fix and long-term success likely depends on ongoing lifestyle support.
